{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:04:45Z","timestamp":1792436685454,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,10]]},"DOI":"10.7759\/cureus.57962","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T13:59:06Z","timestamp":1712757546000},"source":"Crossref","is-referenced-by-count":1,"title":["Folic Acid in the Treatment of Sickle Cell Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Divine Besong","family":"Arrey Agbor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Panday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrah","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simhachalam","family":"Gurugubelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suviksh K","family":"Prathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneisi","family":"Palou Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondos T","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell KL","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010, 38:S512-21. 10.1016\/j.amepre.2009.12.022","journal-title":"Am J Prev Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/156652408786241375","article-title":"Hemoglobinopathies worldwide: present and future","volume":"8","author":"Weatherall DJ","year":"2008","unstructured":"Weatherall DJ. Hemoglobinopathies worldwide: present and future. Curr Mol Med. 2008, 8:592-9. 10.2174\/156652408786241375","journal-title":"Curr Mol Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse SD","year":"2011","unstructured":"Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011, 41:S398-405. 10.1016\/j.amepre.2011.09.013","journal-title":"Am J Prev Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00004-7","article-title":"Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study","volume":"9","author":"Ranque B","year":"2022","unstructured":"Ranque B, Kitenge R, Ndiaye DD, et al.. Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study. Lancet Haematol. 2022, 9:e208-16. 10.1016\/S2352-3026(22)00004-7","journal-title":"Lancet Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3885979","article-title":"Sickle cell disease in children and adolescents: a review of the historical, clinical, and public health perspective of sub-Saharan Africa and beyond","volume":"2022","author":"Egesa WI","year":"2022","unstructured":"Egesa WI, Nakalema G, Waibi WM, et al.. Sickle cell disease in children and adolescents: a review of the historical, clinical, and public health perspective of sub-Saharan Africa and beyond. Int J Pediatr. 2022, 2022:3885979. 10.1155\/2022\/3885979","journal-title":"Int J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh PL","year":"2022","unstructured":"Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. JAMA. 2022, 328:57-68. 10.1001\/jama.2022.10233","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/hemato3020024","article-title":"Sickle cell disease, a review","volume":"3","author":"Tebbi CK","year":"2022","unstructured":"Tebbi CK. Sickle cell disease, a review. Hemato. 2022, 3:341-66. 10.3390\/hemato3020024","journal-title":"Hemato"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart M","year":"2004","unstructured":"Stuart M, Nagel R. Sickle-cell disease. Lancet. 2004, 364:1343-60. 10.1016\/S0140-6736(04)17192-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200211000-00008","article-title":"Home management of pain in sickle cell disease: a daily diary study in children and adolescents","volume":"24","author":"Dampier C","year":"2002","unstructured":"Dampier C, Ely E, Brodecki D, O'Neal P. Home management of pain in sickle cell disease: a daily diary study in children and adolescents. J Pediatr Hematol Oncol. 2002, 24:643-7. 10.1097\/00043426-200211000-00008","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","volume":"18","author":"Eaton WA","year":"2017","unstructured":"Eaton WA, Bunn HF. Treating sickle cell disease by targeting HbS polymerization. Blood. 2017, 18:2719-26. 10.1182\/blood-2017-02-765891","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1036939","article-title":"Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: a review","volume":"10","author":"Bhalla N","year":"2023","unstructured":"Bhalla N, Bhargav A, Yadav SK, Singh AK. Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: a review. Front Med (Lausanne). 2023, 10:1036939. 10.3389\/fmed.2023.1036939","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2020.11.8.7","article-title":"Voxelotor: a hemoglobin S polymerization inhibitor for the treatment of sickle cell disease","volume":"11","author":"Yenamandra A","year":"2020","unstructured":"Yenamandra A, Marjoncu D. Voxelotor: a hemoglobin S polymerization inhibitor for the treatment of sickle cell disease. J Adv Pract Oncol. 2020, 11:873-7. 10.6004\/jadpro.2020.11.8.7","journal-title":"J Adv Pract Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees D","year":"2010","unstructured":"Rees D, Williams T, Gladwin M. Sickle-cell disease. Lancet. 2010, 376:2018-31. 10.1016\/S0140-6736(10)61029-X","journal-title":"Lancet"},{"key":"ref14","article-title":"Pharmacological management of sickle cell disease","volume":"33","author":"Ndefo UA","year":"2008","unstructured":"Ndefo UA, Maxwell AE, Nguyen H, Chiobi TL. Pharmacological management of sickle cell disease. P T. 2008, 33:238-43.","journal-title":"P T"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021, 372:n160. 10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/02763869.2013.837734","article-title":"Joanna Briggs Institute: an evidence-based practice database","volume":"32","author":"Vardell E","year":"2013","unstructured":"Vardell E, Malloy M. Joanna Briggs Institute: an evidence-based practice database. Med Ref Serv Q. 2013, 32:434-42. 10.1080\/02763869.2013.837734","journal-title":"Med Ref Serv Q"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref19","article-title":"\u00a0Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness","author":"Gierisch J","year":"2014","unstructured":"Gierisch J, Beadles C, Shapiro A, et al.. Health disparities in quality indicators of healthcare among adults with mental illness. Department of Veterans Affairs, Washington (DC); 2014. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK299087\/."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011130.pub3","article-title":"Folate supplementation in people with sickle cell disease","volume":"3","author":"Dixit R","year":"2018","unstructured":"Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, Stover PJ. Folate supplementation in people with sickle cell disease. Cochrane Database Syst Rev. 2018, 3:CD011130. 10.1002\/14651858.CD011130.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.58445\/rars.164","article-title":"Nutritional status of sickle cell patients: a literature review [PREPRINT]","author":"Hur M","year":"2023","unstructured":"Hur M, Durojaye B. Nutritional status of sickle cell patients: a literature review [PREPRINT]. Research Archive of Rising Scholars. 2023, 10.58445\/rars.164","journal-title":"Research Archive of Rising Scholars"},{"key":"ref22","article-title":"A comprehensive updated review on current management of sickle cell anemia","volume":"10","author":"Bhange KK","year":"2021","unstructured":"Bhange KK, Thakre VM, Mahajan UN, Gajbhiye PR. A comprehensive updated review on current management of sickle cell anemia. World J Pharm. 2021, 10:827-42.","journal-title":"World J Pharm"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.08.002","article-title":"Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa","volume":"60","author":"Ally M","year":"2023","unstructured":"Ally M, Balandya E. Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa. Semin Hematol. 2023, 60:192-9. 10.1053\/j.seminhematol.2023.08.002","journal-title":"Semin Hematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/nu16020258","article-title":"Sickle cell disease update: new treatments and challenging nutritional interventions","volume":"16","author":"Bell V","year":"2024","unstructured":"Bell V, Varzakas T, Psaltopoulou T, Fernandes T. Sickle cell disease update: new treatments and challenging nutritional interventions. Nutrients. 2024, 16:258. 10.3390\/nu16020258","journal-title":"Nutrients"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.18051","article-title":"Sickle cell disease: a primary care update","volume":"87","author":"Onimoe G","year":"2020","unstructured":"Onimoe G, Rotz S. Sickle cell disease: a primary care update. Cleve Clin J Med. 2020, 87:19-27. 10.3949\/ccjm.87a.18051","journal-title":"Cleve Clin J Med"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.2499.2499","article-title":"Nutritional status and hydroxyurea use among children with sickle cell disease in Malawi","volume":"128","author":"Ellis G","year":"2016","unstructured":"Ellis G, Chipoka G, Mafunga P, et al.. Nutritional status and hydroxyurea use among children with sickle cell disease in Malawi. Blood. 2016, 128:2499.","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2019.01.014","article-title":"Sickle cell disease: monitoring, current treatment, and therapeutics under development","volume":"33","author":"Hoppe C","year":"2019","unstructured":"Hoppe C, Neumayr L. Sickle cell disease: monitoring, current treatment, and therapeutics under development. Hematol Oncol Clin North Am. 2019, 33:355-71. 10.1016\/j.hoc.2019.01.014","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25129","article-title":"Nutritional supplement profile of adults with sickle cell disease","author":"Crouch EM","year":"2018","unstructured":"Crouch EM, Bonham VL, Abdallah K, Buscetta A, Vinces G, Heo M, Minniti CP. Nutritional supplement profile of adults with sickle cell disease. Am J Hematol. 2018, 10.1002\/ajh.25129","journal-title":"Am J Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.642306","article-title":"Detectable unmetabolized folic acid and elevated folate concentrations in folic acid-supplemented Canadian children with sickle cell disease","volume":"8","author":"Williams BA","year":"2021","unstructured":"Williams BA, Mayer C, McCartney H, et al.. Detectable unmetabolized folic acid and elevated folate concentrations in folic acid-supplemented Canadian children with sickle cell disease. Front Nutr. 2021, 8:642306. 10.3389\/fnut.2021.642306","journal-title":"Front Nutr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4314\/mmj.v34i2.9","article-title":"Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study","volume":"34","author":"Nnajekwu UC","year":"2022","unstructured":"Nnajekwu UC, Nnajekwu CO, Onukwuli VO, Chukwu BF, Ikefuna AN, Emodi IJ. Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study. Malawi Med J. 2022, 34:132-7. 10.4314\/mmj.v34i2.9","journal-title":"Malawi Med J"},{"key":"ref31","article-title":"Present knowledge in nutrition","author":"Erdman JW","year":"2012","unstructured":"Erdman JW, MacDonald IA, Zeisel SH. Present knowledge in nutrition. Wiley-Blackwell, Hoboken (NJ); 2012."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/791498","article-title":"Management of sickle cell disease: a review for physician education in Nigeria (sub-Saharan Africa)","volume":"2015","author":"Adewoyin AS","year":"2015","unstructured":"Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (sub-Saharan Africa). Anemia. 2015, 2015:791498. 10.1155\/2015\/791498","journal-title":"Anemia"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2021.1880752","article-title":"Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo","volume":"26","author":"Kambale-Kombi P","year":"2021","unstructured":"Kambale-Kombi P, Marini Djang'eing'a R, Alworong'a Opara JP, et al.. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. Hematology. 2021, 26:199-205. 10.1080\/16078454.2021.1880752","journal-title":"Hematology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5020020","article-title":"Sickle cell disease-genetics, pathophysiology, clinical presentation and treatment","volume":"5","author":"Inusa BP","year":"2019","unstructured":"Inusa BP, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, Atoyebi W. Sickle cell disease-genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019, 5:20. 10.3390\/ijns5020020","journal-title":"Int J Neonatal Screen"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/20014091084209","article-title":"Folic acid","volume":"38","author":"Donnelly JG","year":"2001","unstructured":"Donnelly JG. Folic acid. Crit Rev Clin Lab Sci. 2001, 38:183-223. 10.1080\/20014091084209","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21838","article-title":"Leg ulcers in sickle cell disease","volume":"85","author":"Minniti CP","year":"2010","unstructured":"Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol. 2010, 85:831-3. 10.1002\/ajh.21838","journal-title":"Am J Hematol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4137\/NMI.S5048","article-title":"The role of nutrition in sickle cell disease","volume":"3","author":"Hyacinth HI","year":"2010","unstructured":"Hyacinth HI, Gee BE, Hibbert JM. The role of nutrition in sickle cell disease. Nutr Metab Insights. 2010, 3:57-67. 10.4137\/NMI.S5048","journal-title":"Nutr Metab Insights"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/1534734617737639","article-title":"Nutrition and lower extremity ulcers: causality and\/or treatment","volume":"16","author":"Haughey L","year":"2017","unstructured":"Haughey L, Barbul A. Nutrition and lower extremity ulcers: causality and\/or treatment. Int J Low Extrem Wounds. 2017, 16:238-43. 10.1177\/1534734617737639","journal-title":"Int J Low Extrem Wounds"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122918","article-title":"Vitamin B2 and folate concentrations are associated with ARA, EPA and DHA fatty acids in red blood cells of Brazilian children and adolescents","volume":"11","author":"Ued FV","year":"2019","unstructured":"Ued FV, Mathias MG, Toffano RB, et al.. Vitamin B2 and folate concentrations are associated with ARA, EPA and DHA fatty acids in red blood cells of Brazilian children and adolescents. Nutrients. 2019, 11:2918. 10.3390\/nu11122918","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2012-301885.219","article-title":"Folic acid supplementation in children with sickle cell disease","volume":"97","author":"Al-Yassin A","year":"2012","unstructured":"Al-Yassin A, Osei A, Rees D. Folic acid supplementation in children with sickle cell disease. Arch Dis Child. 2012, 97:91-2.","journal-title":"Arch Dis Child"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830240416","article-title":"Nutrition and sickle cell disease","volume":"24","author":"Reed JD","year":"1987","unstructured":"Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell disease. Am J Hematol. 1987, 24:441-55. 10.1002\/ajh.2830240416","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/241651-folic-acid-in-the-treatment-of-sickle-cell-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T13:59:12Z","timestamp":1712757552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/241651-folic-acid-in-the-treatment-of-sickle-cell-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.57962","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,10]]}}}